New tool makes gene regulation easier to study—and tweak

Leuven, 2 April 2026 - Understanding how genes are switched on and off in specific cell types remains one of biology’s central challenges. While AI has made major progress in decoding the regulatory logic of DNA, applying these approaches across datasets, tissues, and species has remained difficult. In a new Nature Methods paper, a research team led by Prof. Stein Aerts (VIB & KU Leuven) presents CREsted, a software package that enables both the analysis and design of gene regulatory elements in a systematic and scalable way.

Enhancers are gene regulatory elements—short DNA sequences that control when and where genes are active. Deep learning models can help decode this “regulatory code”, but existing approaches are often tailored to one dataset or one task, making them hard to reuse or extend.

To address this, Prof. Stein Aerts and his team developed CREsted, a new framework that turns enhancer modeling from a collection of one-off analyses into a more systematic and reusable workflow.

“We wanted to move beyond one-off models,” says Niklas Kempynck, PhD student in the Aerts lab. “CREsted allows researchers to systematically study enhancer logic across biological systems, starting from cell-by-cell maps of accessible regulatory DNA and going all the way to sequence design.”

CREsted brings together several steps that are usually handled separately: preprocessing, model training, interpretation, and synthetic enhancer design. It is also built to fit into existing single-cell analysis workflows, making it easier for researchers to adopt and use.

Prof. Stein Aerts, Dr. Seppe De Winter, and Niklas Kempynck
“With CREsted, we give researchers a complete workflow,” says Dr. Seppe De Winter, who shares first authorship with Kempynck. “You can train deep learning models on chromatin accessibility data, interpret which regulatory features they capture, and then use those models to design new DNA sequences with predicted cell-type-specific activity.”

To show its versatility, the team applied CREsted to multiple systems, including mouse brain tissue, human immune cells, cancer cell states, and zebrafish development. Across these settings, the framework identified regulatory patterns, predicted enhancer activity, and enabled the design of synthetic enhancers, which were validated in vivo in zebrafish.

For Prof. Stein Aerts, Scientific Director of VIB.AI, the strength of CREsted lies in making a powerful development more coherent and reusable.

“CREsted makes it much easier to train, interpret, and compare enhancer models across datasets,” he says. “That is important if we want these approaches to become broadly useful, not just for understanding regulatory DNA, but also for designing and testing new sequences in a systematic way.”

Taken together, the work shows how AI can help move the field from describing regulatory DNA to actively exploring and designing it. With applications ranging from fundamental biology to biotechnology and medicine, CREsted lays the groundwork for more systematic and programmable control of gene regulation.


Publication

CREsted: modeling genomic and synthetic cell type-specific enhancers across tissues and species. Kempynck, De Winter et al. Nature Methods, 2026. DOI: https://doi.org/10.1038/s41592-026-03057-2

Funding

This research was funded in part by Aligning Science Across Parkinson’s through the Michael J. Fox Foundation for Parkinson’s Research (MJFF); the European Research Council, the Chan-Zuckerberg Initiative, the Research Foundation Flanders - FWO, and the Foundation Against Cancer. For all funders, see the paper’s acknowledgements.

 

Share

Latest stories

Website preview
Prof. Diether Lambrechts (KU Leuven/VIB) receives the Francqui-Collen Prize 2026
Brussels, June 2, 2026 – Prof. Dr. Diether Lambrechts (KU Leuven/VIB) and Prof. Dr. Patrice Cani (UCLouvain) are the laureates of the Francqui-Collen Prize 2026, one of the highest scientific distinctions in Belgium. Today, they receive the award from the hands of King Philippe. Prof. Lambrechts is being honored for his groundbreaking genetic research into cancer treatments, while Prof. Cani is recognized for his discoveries regarding the impact of gut bacteria on lifestyle-related diseases.
press.vib.be
Website preview
Comprehensive atlas maps dendritic cells across cancers
Brussels, 01 June 2026 — Researchers from VIB, VUB, and an international network of collaborators have created the most comprehensive single-cell atlas to date of tumor-associated dendritic cells. By integrating data from 14 mouse tumor models and 10 human cancer types, the study provides a detailed, cross-species view of how these key immune cells are organized and altered in cancer. This work, which appeared in Nature Communications, can guide the development of next-generation therapies.
press.vib.be
Website preview
Scientists reveal how developing immune cells fine-tune their signals
Ghent, 27 May 2026 - Researchers at VIB, Ghent University, and VUB have uncovered how two proteins essential for immune cell development work together at the molecular level. The findings provide important insights into a critical mechanism that mediates the integration of molecular signals received from immunological threats. Their work appears in Nature Communications.
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be